Ignite Creation Date:
2024-05-06 @ 7:23 PM
Last Modification Date:
2024-10-26 @ 3:05 PM
Study NCT ID:
NCT05991895
Status:
RECRUITING
Last Update Posted:
2023-08-15
First Post:
2023-08-08
Brief Title:
Real-World Study of Iruplinalkib in the Treatment of ALK-Positive Non-Small Cell Lung Cancer
Sponsor:
Jinming Yu
Organization:
Shandong Cancer Hospital and Institute
Study Overview
Official Title:
Real-World Study of Iruplinalkib in the Treatment of ALK-Positive Non-Small Cell Lung Cancer
Status:
RECRUITING
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a national multicenter real-world investigation aimed at evaluating the real-world effectiveness and safety of Iruplinalkib in the treatment of ALK-positive NSCLC in China
The study aims to enroll ALK-positive NSCLC patients who have undergone treatment with Iruplinalkib prior to enrollment Demographic information medical history Iruplinalkib-containing treatment regimens clinical outcomes adverse events and related data will be collected for all enrolled patients
As this study is a real-world investigation treatment procedures visit schedules and examinations will be based on the routine clinical practice of physicians The primary sources of data for this study will mainly consist of patients routine medical records or healthcare documentation
The study aims to enroll ALK-positive NSCLC patients who have undergone treatment with Iruplinalkib prior to enrollment Demographic information medical history Iruplinalkib-containing treatment regimens clinical outcomes adverse events and related data will be collected for all enrolled patients
As this study is a real-world investigation treatment procedures visit schedules and examinations will be based on the routine clinical practice of physicians The primary sources of data for this study will mainly consist of patients routine medical records or healthcare documentation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None